User menu

Agonist and antagonist modulation of [35S]-GTP gamma S binding in transfected CHO cells expressing the neurotensin receptor.

Bibliographic reference Hermans, Emmanuel ; Geurts, M ; Maloteaux, Jean-Marie. Agonist and antagonist modulation of [35S]-GTP gamma S binding in transfected CHO cells expressing the neurotensin receptor.. In: British journal of pharmacology, Vol. 121, no. 8, p. 1817-23 (1997)
Permanent URL http://hdl.handle.net/2078.1/12360
  1. Ahmad, Biochim. Biophys. Acta, 896, 224 (1987)
  2. Akunne, Biochem. Pharmacol., 49, 1147 (1995)
  3. Azzi, Eur. J. Pharmacol., 255, 167 (1994)
  4. Babich, J. Pharmacol. Exp. Ther., 269, 172 (1994)
  5. Betancur, J. Pharmacol. Exp. Ther., 273, 1450 (1995)
  6. Birnbaumer Lutz, Abramowitz Joel, Brown Arthur M., Receptor-effector coupling by G proteins, 10.1016/0304-4157(90)90007-y
  7. Booudin, Biochem. Pharmacol., 51, 1243 (1996)
  8. Bozou, Mol. Pharmacol., 29, 489 (1986)
  9. Bozou J C, Rochet N, Magnaldo I, Vincent J P, Kitabgi P, Neurotensin stimulates inositol trisphosphate-mediated calcium mobilization but not protein kinase C activation in HT29 cells. Involvement of a G-protein, 10.1042/bj2640871
  10. Brouard, Eur. J. Pharmacol., 253, 289 (1994)
  11. Carraway, Peptides, 14, 37 (1993)
  12. Chabry, J. Neurochem., 63, 19 (1994)
  13. Dubuc, Eur. J. Pharmacol., 219, 327 (1992)
  14. Florio, J. Biol. Chem., 264, 3909 (1989)
  15. Fu, Regul. Pept., 31, 167 (1992)
  16. Giershik, Eur. J. Biochem., 197, 725 (1991)
  17. Oilman, Ann. Rev. Biochem., 56, 615 (1987)
  18. Goedert, Brain Res., 32, 193 (1984)
  19. Gully, Proc. Natl. Acad. Sci. U.S.A., 90, 65 (1993)
  20. Hermans, J. Neurochem., 64, 2518 (1995)
  21. Hermans, Mol. Brain Res., 15, 332 (1992)
  22. Hermans, Biochem. Pharmacol., 47, 89 (1994)
  23. Hermans, Mol. Pharmacol., 49, 365 (1996)
  24. Hilf, Eur. J Biochem., 186, 725 (1989)
  25. Kalivas, Brain Res. Rev., 18, 75 (1993)
  26. Kitabgi, Peptides, 5, 917 (1984)
  27. Kitabgi, Eur. J. Pharmacol., 140, 285 (1987)
  28. Labbe-Jullie, Mol. Pharmacol., 47, 1050 (1995)
  29. Labbe-Jullie, J. Pharmacol. Exp. Ther., 271, 267 (1994)
  30. Lorenzen, Mol. Pharmacol., 44, 115 (1993)
  31. Mazella, Brain Res., 564, 249 (1991)
  32. Minamino, Biochem. Biophys. Res. Commun., 122, 542 (1984)
  33. Nanoff, Mol. Pharmacol., 48, 806 (1995)
  34. Nisato, Life Sci., 54, PL95 (1994)
  35. Oury-Donat F., Thurneyssen O., Gonalons N., Forgez P., Gully D., Fur G. Le, Soubrie P., Characterization of the effect of SR48692 on inositol monophosphate, cyclic GMP and cyclic AMP responses linked to neurotensin receptor activation in neuronal and non-neuronal cells, 10.1111/j.1476-5381.1995.tb16680.x
  36. Pugsley, Peptides, 16, 37 (1995)
  37. Reithmann, Arch. Toxicol., 65, 518 (1991)
  38. Sadoul, Biochem. Biophys. Res. Commun., 120, 206 (1984)
  39. Schaeffer, J. Biol. Chem., 270, 3409 (1995)
  40. Slusher, Mol. Pharmacol., 46, 115 (1994)
  41. Smith, J. Pharmacol. Exp. Ther., 253, 688 (1990)
  42. Tanaka, Neuron, 4, 847 (1990)
  43. Taylor C W, The role of G proteins in transmembrane signalling, 10.1042/bj2720001
  44. Thompson, J. Biol. Chem., 266, 23856 (1991)
  45. Traynor, Mol. Pharmacol., 47, 848 (1995)
  46. Watson, J. Neurochem., 59, 1967 (1992)
  47. Wong, J. Pharmacol. Exp. Ther., 268, 653 (1994)
  48. Wu, Neurosci. Lett., 184, 121 (1995)
  49. Yamada, J. Pharmacol. Exp. Ther., 267, 128 (1993)
  50. Yule, J. Biol. Chem., 267, 13830 (1992)